(Q48152524)

9 February 2018

title

Opiate receptor avidity is reduced bilaterally in rhesus monkeys unilaterally lesioned with MPTP. (English)

1 reference

9 February 2018

author name string

Cohen RM

1

1 reference

9 February 2018

Carson RE

2

1 reference

9 February 2018

Wyatt RJ

3

1 reference

9 February 2018

Doudet DJ

4

1 reference

9 February 2018

publication date

1 September 1999

1 reference

9 February 2018

published in

Synapse

1 reference

9 February 2018

volume

33

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

282-288

1 reference

9 February 2018

Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Naloxone reverses L-dopa induced overstimulation effects in a Parkinson's disease animal model analogue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Opiate receptor avidity is reduced in non-motor impaired MPTP-lesioned rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Enkephalins and nigrostriatal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Neurotransmitters and neuromodulators in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

The actions of opiates in the rat substantia nigra: an electrophysiological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Enkephalinergic Markers in Substantia Nigra and Caudate Nucleus from Parkinsonian Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Alterations in brain opiate receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

The localization of receptor binding sites in the substantia nigra and striatum of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Naloxone does not benefit levodopa-induced hallucinations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem Parkinsonian brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative r

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Prefrontal Corticostriatal Afferents Maintain Increased Enkephalin Gene Expression in the Dopamine-denervated Rat Striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: Quantification using the rotational model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Striatal opiate receptors: Pre- and postsynaptic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Substantia nigra opiate receptors on basal ganglia efferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%2819990915%2933%3A4%3C282%3A%3AAID-SYN5%3E3.0.CO%3B2-5

10.1002/(SICI)1098-2396(19990915)33:4<282::AID-SYN5>3.0.CO;2-5

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

release_5nhhww3i5ffljgcoisccsqzrqy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5nhhww3i5ffljgcoisccsqzrqy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 February 2018